Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.46 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CHKA | P35790 | 1/20 | 0.37 |
| ▸ | KDM5C | P41229 | 1/20 | 0.37 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29299554 | 1.00 | CHRM5 (0.50) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| SCHEMBL472213 | 1.00 | CHRM5 (0.50) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| SCHEMBL27229072 | 0.98 | CHRM5 (0.48) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| SCHEMBL5550813 | 0.98 | CHRM5 (0.48) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| SCHEMBL5239633 | 0.98 | CHRM5 (0.48) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| Hydrochloric Acid SCHEMBL28968883 | 0.98 | CHRM5 (0.48) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| SCHEMBL8038178 | 0.98 | CHRM5 (0.48) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| SCHEMBL6537424 | 0.98 | CHRM5 (0.48) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| SCHEMBL10567168 | 0.98 | CHRM5 (0.48) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 | |
| SCHEMBL337070 | 0.98 | HSD17B10 (0.52) | CHRM5CHRM3HSD17B10SIGMAR1SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3557 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661737-B | Polysaccharide contrast agent capable of being metabolized by kidneys and preparation method thereof | 四川大学 | 2026-05-22 | — | — | CN | claimed |
| US-20260137819-A1 | FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR) TARGETED THERAPEUTICS AND USES THEREOF | RADIONETICS ONCOLOGY INC (US) | 2026-05-21 | — | — | US | claimed |
| EP-4743489-A1 | HUMANISED ANTIBODIES AND USES THEREOF | Telix Pharmaceuticals (Innovations) Pty Ltd (AU) | 2026-05-20 | — | — | EP | claimed |
| CN-121045338-B | Cyclic peptide targeting CAIX and preparation method and application thereof | 原子高科股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026099626-A1 | METHODS AND SYSTEMS FOR MANUFACTURING RADIOPHARMACEUTICALS | NOVARTIS AG (CH) | 2026-05-15 | — | — | WO | claimed |
| WO-2026098617-A1 | RADIOPHARMACEUTICAL TARGETING CARBONIC ANHYDRASE IX PROTEIN | 无锡诺宇医药科技有限公司 | 2026-05-15 | — | — | WO | claimed |
| US-20260131036-A1 | CD138/SYNDECAN1 ANTIBODIES AND METHODS OF USE THEREOF | UNIV TEXAS (US) | 2026-05-14 | — | — | US | claimed |
| US-20260131034-A1 | RADIOPHARMACEUTICALS TARGETING CARBONIC ANHYDRASE IX PROTEINS | NORROY BIOSCIENCE CO LTD (CN) | 2026-05-14 | — | — | US | claimed |
| CN-122005879-A | Modified GRPR antagonist peptides for cancer imaging and treatment | 慕尼黑工业大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122012673-A | ICP-MS analysis method for simultaneously detecting multiple respiratory pathogens by combining CRISPR/Cas12a with DNA nanomachines | 四川大学 | 2026-05-12 | — | — | CN | claimed |
| EP-0442962-B1 | LIPOSOMAL RADIOLOGIC CONTRAST AGENTS | UNGER EVAN C (US) | 1994-01-05 | — | — | EP | claimed |
| WO-1993006868-A1 | DENDRIMERIC POLYCHELANTS | COCKBAIN, Jilian, Roderick, Michaelson (GB) | 1993-04-15 | — | — | WO | claimed |
| US-5133956-A | Radiolabeled metal-binding protein for the treatment of arthritis | THE DOW CHEMICAL COMPANY (US) | 1992-07-28 | — | — | US | claimed |
| EP-0474642-A1 | CHELANTS. | SALUTAR INC (US) | 1992-03-18 | — | — | EP | claimed |
| EP-0454078-A2 | Dual functioning excipient for metal chelate contrast agents | BRACCO INTERNATIONAL B.V. (NL) | 1991-10-30 | — | — | EP | claimed |
| EP-0232751-B1 | 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECANE AND ANALOGS | E.R. Squibb & Sons, Inc. (US) | 1991-09-11 | — | — | EP | claimed |
| WO-1990012050-A1 | CHELANTS | SALUTAR, INC. (US) | 1990-10-18 | — | — | WO | claimed |
| US-4885363-A | RADIOPHARMACEUTICAL IMAGING; MEDICAL DIAGNOSIS | E. R. SQUIBB & SONS, INC. (US) | 1989-12-05 | — | — | US | claimed |
| EP-0292689-A2 | Substituted 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclo-dodecane and analogs | BRACCO INTERNATIONAL B.V. (NL) | 1988-11-30 | — | — | EP | claimed |
| EP-0232751-A1 | 1-substituted-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs | E.R. Squibb & Sons, Inc. (US) | 1987-08-19 | — | — | EP | claimed |